WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on1 OCTOBER 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • Scientific Journal Impact Factor (SJIF)
  • IFSIJ Measure of Journal Quality
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database
  • Research Publication Rating and Indexing
  • Doi-Digital Online Identifier
  • ISSN National Centre
  • Zenodo Indexing
  • International CODEN Service, USA

Abstract

ASSESSMENT OF HEPATITIS B AND HEPATITIS C INFECTIONS AMONG PREMARITAL SCREENING APPLICANTS IN MOSUL CITY

Dr. Nada Nazar Qasim Al Safar*, Dr. Ruba Mohammed Ibrahim, Dr. Anfal Mumtaz Ahmed Al Mukhtar

ABSTRACT

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections represent important public health concerns because of their potential to cause chronic liver disease and long-term complications. Premarital screening provides an opportunity to identify individuals with positive screening results and facilitate appropriate counselling and clinical assessment. Objectives: To assess HBV and HCV screening positivity among premarital screening applicants in Mosul City, Iraq, and describe its distribution according to year and sex. Methods: A retrospective cross-sectional study was planned at Ibn Sina Teaching Hospital, Ibn Al-Atheer Teaching Hospital, and Mosul General Hospital for the period from January 2, 2021, to December 31, 2024. The available aggregate screening records included 56180 applicants from 2021–2024. HBV screening was based on hepatitis B surface antigen (HBsAg), while HCV screening was based on anti-HCV antibodies. Results: Among 56180 applicants, 146 were HBsAg-positive, yielding an HBV screening positivity rate of 0.26%, while 26 were anti-HCV-positive, corresponding to 0.046%. HBV positivity was 0.471% in 2021, 0.240% in 2022, 0.305% in 2023, and 0.164% in 2024. HCV positivity was 0.114%, 0.060%, 0.052%, and 0.017%, respectively. Males accounted for 94 (64.38%) of HBV-positive cases and 17 (65.38%) of anti-HCV-positive cases. Conclusions: The available records demonstrated low screening positivity for HBV and HCV among premarital screening applicants in Mosul, with a higher proportion of male cases. Continued premarital screening, appropriate counselling, clinical referral, and HBV vaccination for susceptible individuals are recommended. HCV RNA testing is required to confirm active HCV infection.

[Full Text Article] [Download Certificate]